Back to search

Clemson University

Vascular Tissue Engineering in Metabolic Syndrome Conditions – in vitro Studies

Abstract

dc:description.abstract

Cardiovascular disease (CVD) is on the rise in the US and is the leading cause of death worldwide [1]. Associated disorders including stenosis of the vasculature and formation of atherosclerotic plaques can necessitate the need for repair or replacement. Tissue engineering, based on stem cells and scaffolds, is an emerging strategy for the treatment of vascular diseases. Patients who typically require vascular replacement often have comorbidities such as diabetes and hypertension. There remains the challenge of understanding the fate of tissue engineered vascular grafts (TEVGs) in a harsh diabetic environment. In these experiments we aimed to develop an in-vitro vascular bioreactor model to 1) condition our tissue engineered vascular grafts and 2) model both a hyperglycemic and hypertensive environment. Our goal was to illicit an appropriate response from the vascular grafts caused by exposure to these pathologic environments to better inform us regarding the fate of our grafts before requiring an in-vivo model.

Degree

thesis:*
Name thesis:degree_name
Master of Science (MS)
Level thesis:degree_level
Thesis
Discipline thesis:degree_discipline
Bioengineering

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Carter, Anna Lu
Contributors dc:contributor
  • Agneta Simionescu
  • Dan Simionescu
  • Leslie Sierad

Subjects

dc:subject × 5

Identifiers

dc:identifier.*
Repository record dc:identifier
https://open.clemson.edu/all_theses/3240

Chain of custody

source
Harvested from
Clemson University
Base URL
open.clemson.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Carter, Anna Lu. Vascular Tissue Engineering in Metabolic Syndrome Conditions – in vitro Studies. Thesis thesis, https://open.clemson.edu/all_theses/3240